Michael King

Insider Reports History

Entity
Individual
Location
2100 East 54 Th Street North, Sioux Falls, SD
Signature
/s/ Michael G. King, Jr.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael King:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 5K $4.4K $0.88 Nov 30, 2023 Direct
SAB Biotherapeutics, Inc. CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 115K Feb 21, 2024 Direct

Insider Reports Filed by Michael King

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SABS SAB Biotherapeutics, Inc. Feb 21, 2024 1 $0 4 Feb 23, 2024 CHIEF FINANCIAL OFFICER
SABS SAB Biotherapeutics, Inc. Nov 30, 2023 1 $4.5K 4 Nov 30, 2023 CHIEF FINANCIAL OFFICER
SABS SAB Biotherapeutics, Inc. Oct 30, 2023 1 $0 4 Nov 3, 2023 CHIEF FINANCIAL OFFICER
SABS SAB Biotherapeutics, Inc. Oct 30, 2023 0 $0 3 Nov 3, 2023 CHIEF FINANCIAL OFFICER